Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis

BACKGROUND AND PURPOSE: Oxidative stress has been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Edaravone, a free radical scavenger, was approved as a therapeutic drug for ALS in 2015 in Japan. A phase 3 clinical trial demonstrated a smaller decline in ALS functional scale s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:eNeurologicalSci
Autors principals: Okada, Masamitsu, Yamashita, Satoshi, Ueyama, Hidetsugu, Ishizaki, Masatoshi, Maeda, Yasushi, Ando, Yukio
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006910/
https://ncbi.nlm.nih.gov/pubmed/29928711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ensci.2018.05.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars